EHC
Encompass Health Corp
122.20$
-0.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.1% | 13.0% | 14.0% | 14.3% | 12.7% | 12.4% | 14.7% | 13.4% | 12.7% | 13.8% | 13.6% | 12.8% | |
| 2.0% | 1.3% | 0.9% | 1.1% | 1.3% | 1.6% | 3.5% | 0.7% | 0.4% | 1.7% | 1.3% | 1.5% | |
| 2.0% | 1.3% | 0.9% | 1.1% | 1.3% | 1.6% | 3.5% | 0.7% | 0.4% | 2.3% | 1.3% | 2.0% | |
| 9.5% | 8.9% | 9.5% | 9.6% | 8.9% | 8.2% | 8.7% | 7.3% | 9.5% | 10.0% | 9.2% | 8.7% | |
| 6.9% | 1.0% | 1.3% | 1.3% | 1.1% | 0.9% | 1.0% | 0.9% | 0.6% | 1.2% | – | – | |
| 29.9% | 28.4% | 29.7% | 31.0% | 31.3% | 32.2% | 38.0% | 41.4% | 55.9% | 57.5% | 58.9% | 60.9% | |
| 31.8% | 41.0% | 41.2% | 40.3% | 40.2% | 37.9% | 36.0% | 18.0% | 22.4% | 21.0% | 19.6% | 18.6% | |
| 9.0% | 9.1% | 8.8% | 8.2% | 8.5% | 7.8% | 6.7% | 2.3% | 5.0% | 4.6% | 4.6% | 4.3% | |
| 76.6% | 80.5% | 77.2% | 66.4% | 64.2% | 68.2% | 68.9% | 65.1% | 67.0% | 62.4% | 56.4% | 53.8% | |
| 10.7% | 9.3% | 10.2% | 10.6% | 12.9% | 11.9% | 11.1% | 10.9% | 10.2% | 10.8% | 12.9% | 11.8% | |
| 0.6% | 0.8% | 0.8% | 0.7% | 0.7% | 1.3% | 1.3% | 0.9% | 0.9% | 0.8% | 2.5% | 1.0% | |
| 1.6% | 1.3% | 1.5% | 1.6% | 1.7% | 1.6% | 1.8% | 2.0% | 2.4% | 2.8% | 2.6% | 2.5% | |
| 61.9% | 68.1% | 63.6% | 52.0% | 47.4% | 49.7% | 50.4% | 47.3% | 48.6% | 44.0% | 36.1% | 34.5% | |
| 16.6% | 13.3% | 15.7% | 24.1% | 25.4% | 22.2% | 24.6% | 27.8% | 23.2% | 27.0% | 31.6% | 34.4% | |
| -55.1% | -36.8% | -30.9% | -24.3% | -16.9% | -8.7% | -3.8% | 2.1% | 2.1% | 6.7% | 12.2% | 18.2% | |
| 3.0% | 2.2% | 2.1% | 2.0% | 1.9% | 1.6% | 1.5% | 1.5% | 1.8% | 1.7% | 1.6% | 1.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.